Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Journal of the National Cancer Institute|June 2, 2010
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolismZachary J Reitman, Hai YanCancer Cell|March 16, 2010
IDH1 and IDH2: not your typical oncogenesZachary J Reitman, D Williams Parsons, Hai YanCancer Cell|May 18, 2013
Releasing the block: setting differentiation free with mutant IDH inhibitorsChristopher J Pirozzi, Zachary J Reitman, Hai YanSeminars in Neurology|March 17, 2018
New Directions in the Treatment of GlioblastomaZachary J Reitman, Frank Winkler, Andrew E H EliaSeminars in Radiation Oncology|December 4, 2021
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer PatientsMaría E Guerra García, David G Kirsch, Zachary J ReitmanNPJ Precision Oncology|July 29, 2025
Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncologyAbigail J Groth, Mustafa Khasraw, James D Byrne, et al.Blood|November 16, 2014
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in DrosophilaZachary J Reitman, Sergey A Sinenko, Eric P Spana, et al.Journal of Graduate Medical Education|June 5, 2013
Relationship Between Time of First Publication and Subsequent Publication Success Among Non-PhD Physician-ScientistsKevin R Riggs, Zachary J Reitman, Thelma J Mielenz, et al.Neuro-Oncology|January 29, 2024
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomasMatthew S Waitkus, Elise N Erman, Zachary J Reitman, et al.European Journal of Medicinal Chemistry|May 11, 2016
Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogsSatish K Chitneni, Zachary J Reitman, David M Gooden, et al.Pageof 8